Ariosa Diagnostics
Prior to being purchased by Roche, Ariosa was a company that designed, developed, and delivered the Harmony Prenatal Test; a cell-free DNA-based non-invasive test. Harmony evaluates possible chromosomal conditions in a pregnancy via a simple blood draw starting at 10 weeks of pregnancy. The company went through multiple name changes (Tandem, Aria, then finalizing on Ariosa). Topsoil assisted the company through its multiple rebrands and helped build its trusted relations with healthcare professionals and patients around the world, making the company a valuable asset for Roche in a $625 million purchase.